





























































































































































































































































0 No increase in tone
1
Slight increase in tone giving a 'catch' when the limb is 
moved in the flexion or extension
2 More marked increase in tone, but limb is easily flexed
3
Considerable increase in tone, passive movement 
difficult




















0 No increase in tone
1 Slight increase in tone - a catch and release at the end of 
the range of motion
1+ Slight increase in tone - catch, followed by minimal 
resistance in remainder of range
2 More marked increase in tone through most of range
3
Considerable increase in tone, passive movement difficult





















V1:  As slow as possible (minimizing stretch reflex)*
V2:  Speed of the limb segment falling under gravity**
V3:  As fast as possible (faster than the rate of the natural drop of the 
limb segment under gravity)**
*V1 measures passive range of motion (PROM)
















































Treatment Plan ↔ Patient Goals 
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Impact Daily Care?
Intrathecal Baclofen
Etiology & 
Pathophysiology
Learning Objectives
Impact of Spasticity & 
Outcome Measures
Definition
Medications
Exam Features
Treatment Plan
Treatment Options
Selective Rhizotomy
Chemodenervation
Summary
References & Resources
Complex Care 
Curriculum Spasticity
Decrease Tone Increase range of motion
Improve fit 
and use of 
orthoses
Decrease 
contractures Delay surgery
Improve 
position for 
care
Improve 
function
Decrease 
caregiver 
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Drug formulation
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Spasticity
Evaluate Patient:
Does spasticity present a 
problem?
No 
treatment
Continual 
re‐assess
NO
Functional 
objectives
Initiate comprehensive 
spasticity management 
program
Technical 
objectives
Patient and 
Caregiver objectives
YES
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Spasticity Management Team
• Patient
• Caregiver
• Pediatrician
• Physiatrist (PMR)
• Neurologist 
• Orthopedic  surgeon
• Neurosurgeon
• Therapist : PT, OT, Speech
• Orthotist and Durable Medical Equipment provider
• Other: Social Work, Dietician, Education specialist
As children age, they may be more likely to need 
orthoses and surgery.
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What is the Role of the Physiatrist?
Function at home and in the community
Orthoses and therapeutic equipment
Altered muscle tone
Facilitating the ability of the child and 
family to set functional goals
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Development Muscle Tone
Pain
Dysautonomia
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Treatment
Therapy
Orthoses
CastingMedications
Surgery
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Oral 
Medications
Intrathecal
baclofen
Selective 
dorsal 
rhizotomy
Chemo‐
denervation
Local 
corrective 
surgery
General
Focal
Reversible Permanent
Surgical and 
Pharmacologic 
Treatment
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Oral medications
Intrathecal
baclofen
Selective dorsal 
rhizotomy
Chemo‐
denervation
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Sedation is one of the common side 
effects with all oral medications
To minimize potential sedation, always 
start low and titrate up slow
Abrupt withdrawal can result in seizures
If NPO, can use IV Diazepam
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AVOID MEDICATION ERROR  
Concentration is variable
1 ml ≠ 1 mg
When prescribing oral baclofen, the dose MUST 
be verified to avoid fatal medication errors!
First Line: Oral Baclofen
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Intrathecal
baclofen:  
50x response 
of oral 
baclofen
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Who is a  candidate?
Severe, generalized tone
Not successfully managed with oral 
medications
Improvement with test dose of intrathecal
baclofen given via lumbar puncture
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PROS: 
GABA inhibition without side 
effects in the brain
Programmable to set best 
dose
CONS: 
Complications of device
High maintenance of 
pump
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Mechanical
• CSF leak
• Catheter 
malfunction
• Infection
Medical
• Overdose
•Withdrawal
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Baclofen withdrawal
Death
Early signs:
Pruritis
Dysphoria
Irritability
Spasticity
Tachycardia
Fever
Hypertension
Respiratory Distress
Late signs:
Hyperthermia
Seizures
Rhabdomyolysis
DIC
Altered Mental Status
Psychomotor agitation
Respiratory Distress
Multisystem Organ Failure
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Troubleshooting 
Pump Failure
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Medications1 Radiographs2 Spiral CT3
Call 
Neurosurgeon!
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What is Selective Rhizotomy?
Isolated Targeted DestroyedNERVES
Improved 
Spasticity
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Who is a Good Candidate?
Ages between 4 and 7 years
“Pure” spasticity
Ambulatory 
Absence of fixed contractures
Cooperation with intensive therapy
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Advantages
• Temporary* 
• Minimally invasive
• Increase ROM
• Learn normal 
movement patterns
• Safely repeated
• Mimic surgical 
outcome
• Allows age‐selective 
timing of surgery
Disadvantages
• Temporary*
• May decrease 
functional tone
• Total body dose of 
toxin limited (BTX‐A)
• Cost (BTX‐A)
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Who is a Good Candidate?
Focal increase in muscle tone
Absence of fixed contractures
Absence of bony/joint problems
No underlying bleeding disorder
Intrathecal Baclofen
Etiology & 
Pathophysiology
Learning Objectives
Impact of Spasticity & 
Outcome Measures
Definition
Medications
Exam Features
Treatment Plan
Treatment Options
Selective Rhizotomy
Chemodenervation
Summary
References & Resources
Complex Care 
Curriculum Spasticity
•May provide 
pain relief, 
improved ease 
of care, 
functional goals
Later Years
•May allow 
postponement, 
simplification, 
avoidance of 
surgery
Early Years
Timing of Botulinum Treatment
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Spasticity = 1 component of the UMN 
syndrome
Spasticity = velocity dependent increased 
resistance to passive stretch
Underlying lesion is static, but 
musculoskeletal pathology is progressive
Treatment plan is not “one‐size fits all”, but 
should be customized to patient’s goals
Most spasticity medications CANNOT be 
stopped abruptly.  Should be weaned to 
avoid seizures, or switched to IV if patient is 
NPO.
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